HOME / NEWS & PERSPECTIVES / Life Sciences

News, stories & opinions for the world’s healthtech innovators.

Life Sciences

Quantum-Si and Planet Innovation to partner on next generation instrumentation

Quantum-Si and Planet Innovation today announced that they will partner on the development and manufacturing of QSI’s next generation instrument program.

Markets.

Diagnostics

Life Sciences

Cell & Gene Therapy

Medical Devices

Topics.

Opinion

Commercialization

Awards

Digital Health

Point-of-Care

Ventures

Corporate

Software

COVID-19

People & Culture

Entrepreneurship

Innovation

Fertility

Lumos Diagnostics

Energy

Manufacturing

Sign up for the Perspectives newsletter:

Point-of-care manufacturing for cell and gene therapies – the debate is heating up

Cell and gene therapies show great promise as cancer treatments. However, patient access, both geographically and financially, is a major challenge to widespread adoption. In order to provide therapies to more patients that desperately need them, the industry is exploring a range of options including point-of-care (POC) manufacturing.

Perspectives from expert roundtable: Strategies to attract funding for C&GT manufacturing tools

Planet Innovation held an exclusive roundtable at Advanced Therapies Week on ‘Strategies to Attract Funding for C&GT Manufacturing Tools’. Here are the highlights

Effective strategies for securing investor funding in cell and gene manufacturing tools development

We share insights from investors on what they prioritize when evaluating funding opportunities for cell and gene therapy tools.

Developing Cell and Gene Therapy Manufacturing Tools

Why creating a successful cell and gene therapy manufacturing tool is about so much more than core tech

Developing an instrument that automates the cell and gene therapy workflow is no easy task. Your core tech, while critical, is only one part of the overall development, there is so much more that determines the success of your product. Brian Hanrahan shares 4 key tips for creating a successful cell therapy manufacturing tool.

Evident Corporation and Planet Innovation enter into long-term strategic partnership

Evident Corporation and Planet Innovation today announced a long-term strategic partnership to develop and manufacture innovative digital workflow solutions for life science markets.

LevitasBio partners with PI to develop and manufacture the world’s first label-free cell separation platform

Silicon Valley start-up LevitasBio has launched the world’s first label-free cell separation platform, the LeviCell™.

If your digital health strategy isn’t driving earnings or learnings, what is it doing?

From start-ups to established companies, almost everyone in the life sciences and diagnostics industries is playing with digital health in one form or another. But how do you ensure this investment translates into commercial success for your company?

The Masterflex® Ismatec® Reglo Digital Pump series.

Cole-Parmer puts user experience at the forefront with new peristaltic pump series

Cole-Parmer's new Masterflex® Ismatec® Reglo Digital Pump series, is not so much an evolution, but a revolution of the popular peristaltic pump range.

IDEX Health & Science launches Tridex™ Protein Analyzer for bioprocessing

IDEX Health & Science has launched the Tridex™ Protein Analyzer, which Planet Innovation helped develop, to measure protein titer directly from a bioreactor in real time.

Gibco CTS Rotea Counterflow Centrifugation System being tested in lab

PI to manufacture Scinogy’s new cell processing system for cell therapy manufacture

Planet Innovation is partnering with Melbourne-based start-up Scinogy to manufacture a revolutionary new cell processing system that is being commercialized by global biotechnology company Thermo Fisher Scientific.

AusBiotech 2018: Putting digital health development under the spotlight

The AusBiotech National Conference, held in sunny Brisbane, brought together national and international leaders from across the life sciences industry. I took the opportunity to pop into a number of sessions on the growing AI and digital health sectors.

Genea’s IVF deal with Merck secures manufacturing contract for PI

Pharmaceutical giant Merck Serono has signed an exclusive deal securing global marketing and commercialization rights to Genea Biomedx’s range of IVF products including Gavi and Geri, which were designed by Genea with development partner, Planet Innovation.

Genea CEO: From idea to Product of the Year

Tomas Stojanov has been an integral part of an extremely successful network of invitro-fertilisation (IVF) clinics in his role as the CEO of fertility group Genea, but his personal dream is to do more. He wanted to change the world of IVF to benefit his company, his industry and most importantly his patients.

How Genea changed the world of IVF through automation

Despite 30 years of IVF practice the process of freezing human embryos, known as vitrification, has remained extremely manual and susceptible to errors and inconsistencies by embryologists. In 2009, Genea Biomedx teamed up with Planet Innovation to solve this challenge by automating IVF vitrification and finally making the process consistent and standardised for labs around the world.